Pioneering Prevention, Precision, & Personalized Brain Health Solutions
Dementia may be managed- Early Action Matters
Pioneering Prevention, Precision, & Personalized Brain Health Solutions
Preventing Dementia: Evidence-Based, Personalized
Preventing Dementia: Evidence-Based, Personalized
Why did we call our website www.stopdementia.com?
As a result of a complex interplay between environmental factors, lifestyle choices, and epigenetic variables, individuals carrying dementia-predisposing genes exhibit considerable variability in the onset of cognitive decline. At StopDementia.com, our mission is to harness cutting-edge, science-based strategies—spanning early detection, precision diagnostics, and personalized interventions—to screen for risk factors and implement an effective multimodal prevention plan. This comprehensive, individualized approach focuses on identifying and modifying changeable contributors—such as diet, physical activity, metabolic health, social interaction, sensory function, and more—that together may account for up to 40% of dementia risk
By intervening early with tailored, evidence-based interventions, we aim to halt or substantially delay the onset of cognitive decline—and challenge the notion that dementia is an inevitable consequence of aging.
Preventing Dementia: Evidence-Based, Personalized
Over 50 million people worldwide live with dementia. Yet, up to 40% of cases are preventable or delayable, and new treatments are changing the course of care. At our center, early detection meets cutting-edge science to slow or even reverse progression in its earliest stages.
Our Brain Longevity Division provides the only outpatient, fully integrated dementia program in the region. From diagnosis to treatment and prevention, we offer a seamless continuum of care.
FDA-Approved Alzheimer’s Therapies
From diagnosis to treatment and prevention, we offer a seamless continuum of care
We are proud to be among the first non-hospital centers in New York City offering access to advanced anti-amyloid biologics - targeting the core pathology of Alzheimer’s disease with precision imaging and expert oversight.
Now Available: Monoclonal antibodies directed against aggregated forms of beta amyloid
Leqembi (lecanemab)
A monoclonal antibody that binds to amyloid-beta plaques, slowing cognitive decline in early-stage Alzheimer’s when paired with monitored infusions and cognitive assessments.
Kisunla (Donanemab)
Amyloid-targeting therapy is administered by IV infusion and guided by amyloid PET imaging and biomarker analysis.
From diagnosis to treatment and prevention, we offer a seamless continuum of care
From diagnosis to treatment and prevention, we offer a seamless continuum of care
Our Brain Longevity Division provides the only outpatient, fully integrated dementia program in the region.
- Cognitive Neurology & Neuropsychology: Comprehensive assessments for memory, attention, language, behavior, and executive function are ideal for early concerns or preventive baselines.
- Neurofeedback-assisted cognitive remediation therapy
- Advanced Brain Imaging: Access high-resolution MRI and PET scans for diagnosis, treatment eligibility, and long-term monitoring of amyloid and tau pathology.
- Biomarker & Genetic Testing: From phosphorylated tau and neurofilament light to APOE genotyping, our lab panel detects preclinical changes, sometimes decades before symptoms appear.
- Digital Brain Health Platform: Remote cognitive testing, personalized coaching, and at-home biomarker tracking—empowering you beyond the clinic.
Your tailored your Brain Health Roadmap includes
- Cognitive Enrichment: Memory training, lifelong learning, language skills
- Exercise: Aerobic fitness that supports hippocampal volume and perfusion
- Nutrition: Mediterranean and MIND diets to reduce inflammation and plaque
- Sleep Optimization: Addressing apnea, improving deep sleep for brain detox
- Hearing Care: Early correction of hearing loss to reduce cognitive strain
- Cardiovascular Health: Managing blood pressure, cholesterol, diabetes
- Mental Wellbeing: Treating depression and reducing chronic stress
- Social & Purposeful Engagement: Building resilience through community and meaning
- An Integrated Practice Model (IPU): We combine neurology, psychiatry, neuroimaging, neuropsychology, therapeutics, and diagnostics into one coordinated team, unique in the region.
- Proactive, Not Reactive: We screen early, track continuously, and treat decisively—long before decline is visible.
- Leaders in Science & Technology: Our team includes national experts in AI-driven diagnostics, neurodegeneration research, and clinical therapeutics.
Skip hospital waitlists
We offer fast-track evaluations, direct access to specialists, and personalized care.
Serving a Growing Need in the NYC Metro Area
1+ million individuals affected by dementia or MCI
270,000+ may qualify for anti-amyloid therapies
600,000+ MRI/PET scans performed yearly—demand is rapidly rising
We are here to meet the challenge with compassion, precision, and hope.
Neurological Research
We are committed to advancing the field of neurology through research. Our team of neurologists conducts clinical trials and research studies to develop new treatments and improve patient outcomes.
Connect with the Brain Longevity Division
Whether you're noticing memory changes, seeking early screening, or evaluating new treatment options, we invite you to take the next step with us.
Let’s change the story of dementia—together.
About Our Practice
Protect, Enhance, Thrive
At our Brain Longevity Division, we dedicate ourselves to preserving, enhancing, and safeguarding your most valuable asset—your brain. Our mission is to empower individuals of all ages with the knowledge, resources, and support necessary to achieve optimal cognitive health, prevent neurodegenerative diseases, and enjoy life to its fullest potential.
Our Philosophy
We understand that brain health is foundational to a vibrant, fulfilling life. Leveraging the latest advancements in neuroscience, integrative medicine, nutrition, and lifestyle sciences, we adopt a comprehensive and holistic approach to cognitive wellness. By integrating cutting-edge diagnostic technologies with individually tailored interventions, our goal goes beyond mere prevention of cognitive decline—we aim to enhance your mental, emotional, and physical vitality.
Our Comprehensive Services
The Brain Longevity Center offers a broad spectrum of specialized services tailored to meet each individual's unique needs:
Comprehensive Cognitive Assessments
Utilizing advanced cognitive evaluations and biomarker analyses, we develop an extensive profile of your brain health, pinpointing specific areas for improvement.
Advanced Neuroimaging
High-Resolution 3T MRI with Volumetric Analysis: Detecting early signs of degenerative brain conditions through sophisticated imaging techniques.
PET & SPECT Imaging: Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) assess brain metabolism and regional blood flow, identifying characteristic metabolic and perfusion patterns associated with Alzheimer’s, Parkinson’s, and frontotemporal dementia. These imaging modalities facilitate early detection, accurate diagnosis, monitoring of disease progression, and evaluation of treatment effectiveness.
Comprehensive Metabolic Evaluations
Detailed assessments of vitamins, micronutrients, hormones, inflammatory markers, and cardiovascular biomarkers critical for brain health.
Quantitative EEG & Brain Mapping
Objective early identification of Dementia with >90% accuracy
Retinal Image & OCT Analysis
Objective early identification of Dementia with >92% accuracy
Polysomnographic Sleep Screening
Identifying and managing sleep disorders that significantly impact cognitive function and brain health.
Genetic Assessments for Dementia Predisposition:
- APOE ε4 Genotyping for late-onset Alzheimer’s disease risk.
- Early-Onset Familial Alzheimer’s Disease (EOFAD): Screening for mutations in APP, PSEN1, PSEN2.
- Frontotemporal Dementia (FTD): Genetic screening including MAPT, GRN, and C9orf72.
- Additional genetic evaluations for conditions such as CADASIL, prion diseases, and Huntington’s disease.